Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:


Cancer: Hot News on Lymphoma

Researchers have found a possible approach for a new therapy of a malignant tumor of the immune system. They present their research in the scientific journal Nature.

The so-called lymphoma, which are cancers of the immune system, originate in white blood cells. Pathological B cells, for instance, are responsible for the "diffuse large B cell lymphoma", which progress very aggressively if left untreated.

In Germany, about 3,000 people are affected by this disease each year. Usually, the patients complain of fever, night sweats and weight loss. Furthermore, they are often pale and tired and exhibit swollen lymph nodes.

25 percent of the patients die

"With a combination treatment of immunotherapy and chemotherapy, this kind of lymphoma can be kept under long-term control or even be cured in about 75 percent of the cases," says Professor Andreas Rosenwald, who works as a pathologist at the University of Würzburg. Why about 25 percent of the patients die from this cancer is still not completely understood at present.

Chronically stimulated protein detected

In recent years, an international research consortium, including Rosenwald's team, has defined two main biologically and clinically distinguishable subgroups of the diffuse large B cell lymphoma.

Now, the researchers have established: In one of these subgroups, a B-cell-specific protein, the so-called B cell receptor, is chronically stimulated. Obviously, this is conducive to the growth of the tumor. "The biological mechanism leading to the continuous stimulation of the receptor was unknown till now. It has been described for the first time in our publication in Nature," explains Rosenwald.

Possible approach for a new therapy

This new finding might be used for future therapy. For instance, it is conceivable that some medication with so-called kinase blockers could be used to curb the out-of-control stimulation. However, this possibility must first be tested in clinical trials over the coming years.

A further assumption must also be examined: There are indications that the chronically stimulated B cell receptor may be responsible for at least some of the cases in which the lymphoma patients die despite receiving treatment.

Eight partners in the consortium

The international consortium that has launched this publication in Nature consists of eight institutions from the USA, Germany, Canada, Norway and Spain. The German contributors to the research are the Würzburg professors Andreas Rosenwald, Hans Konrad Müller-Hermelink and German Ott. Professor Rosenwald has been the director of the Institute of Pathology at the University of Würzburg since September 2009.

Publications in highly regarded journals

"The partners in the consortium have been working closely together since 2000 and this collaboration has proven to be very productive. So far, we have launched about 50 joint publications, several of them in highly regarded journals, such as Nature, Science and the New England Journal of Medicine," says Professor Rosenwald. The success of these studies can only be ascribed to the intensive international teamwork of molecular biologists, genome researchers, hematologists and pathologists - any individual institution would have been overwhelmed by the task.

With its internationally recognized interdisciplinary research projects spanning many years, the consortium has submitted an application for the Team Science Award, a renowned annual award established by the American Association for Cancer Research, which is worth 50,000 dollars in prize money. The scientists consider their chances of winning the award to be quite good.

Lymphoma - a Würzburg specialist field

For the current publication in Nature, Rosenwald's team participated in providing a more detailed pathological and genetic characterization of the respective lymphoma cells in the examined cases. Lymphoma are a specialist field of the Würzburg researchers; the Institute of Pathology at the University of Würzburg is one of six nationwide reference centers for lymph node pathology in Germany.

"Chronic Active B Cell Receptor Signaling in Diffuse Large B Cell Lymphoma", R. Eric Davis, Vu N. Ngo, Georg Lenz, Pavel Tolar, Ryan Young, Paul B. Romesser, Holger Kohlhammer, Laurence Lamy, Hong Zhao, Yandan Yang, Weihong Xu, Arthur L. Shaffer, George Wright, Wenming Xiao, John Powell, Jian-kang Jiang, Craig J. Thomas, Andreas Rosenwald, German Ott, Hans Konrad Muller-Hermelink, Randy D. Gascoyne, Joseph M. Connors, Lisa M. Rimsza, Elias Campo, Elaine S. Jaffe, Jan Delabie, Erlend B. Smeland, Richard I. Fisher, Rita M. Braziel, Raymond R. Tubbs, J. R. Cook, Denny D. Weisenburger, Wing C. Chan, Susan K. Pierce, and Louis M. Staudt. Nature 463, 7. Januar 2010, pp 88-92, doi:10.1038/nature08638


Prof. Dr. Andreas Rosenwald, Institute of Pathology, University of Würzburg, phone +49 931 201-47777,

Robert Emmerich | idw
Further information:

More articles from Life Sciences:

nachricht First time-lapse footage of cell activity during limb regeneration
25.10.2016 | eLife

nachricht Phenotype at the push of a button
25.10.2016 | Institut für Pflanzenbiochemie

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Light-driven atomic rotations excite magnetic waves

Terahertz excitation of selected crystal vibrations leads to an effective magnetic field that drives coherent spin motion

Controlling functional properties by light is one of the grand goals in modern condensed matter physics and materials science. A new study now demonstrates how...

Im Focus: New 3-D wiring technique brings scalable quantum computers closer to reality

Researchers from the Institute for Quantum Computing (IQC) at the University of Waterloo led the development of a new extensible wiring technique capable of controlling superconducting quantum bits, representing a significant step towards to the realization of a scalable quantum computer.

"The quantum socket is a wiring method that uses three-dimensional wires based on spring-loaded pins to address individual qubits," said Jeremy Béjanin, a PhD...

Im Focus: Scientists develop a semiconductor nanocomposite material that moves in response to light

In a paper in Scientific Reports, a research team at Worcester Polytechnic Institute describes a novel light-activated phenomenon that could become the basis for applications as diverse as microscopic robotic grippers and more efficient solar cells.

A research team at Worcester Polytechnic Institute (WPI) has developed a revolutionary, light-activated semiconductor nanocomposite material that can be used...

Im Focus: Diamonds aren't forever: Sandia, Harvard team create first quantum computer bridge

By forcefully embedding two silicon atoms in a diamond matrix, Sandia researchers have demonstrated for the first time on a single chip all the components needed to create a quantum bridge to link quantum computers together.

"People have already built small quantum computers," says Sandia researcher Ryan Camacho. "Maybe the first useful one won't be a single giant quantum computer...

Im Focus: New Products - Highlights of COMPAMED 2016

COMPAMED has become the leading international marketplace for suppliers of medical manufacturing. The trade fair, which takes place every November and is co-located to MEDICA in Dusseldorf, has been steadily growing over the past years and shows that medical technology remains a rapidly growing market.

In 2016, the joint pavilion by the IVAM Microtechnology Network, the Product Market “High-tech for Medical Devices”, will be located in Hall 8a again and will...

All Focus news of the innovation-report >>>



Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

Agricultural Trade Developments and Potentials in Central Asia and the South Caucasus

14.10.2016 | Event News

World Health Summit – Day Three: A Call to Action

12.10.2016 | Event News

Latest News

Enormous dome in central Andes driven by huge magma body beneath it

25.10.2016 | Earth Sciences

First time-lapse footage of cell activity during limb regeneration

25.10.2016 | Life Sciences

Deep down fracking wells, microbial communities thrive

25.10.2016 | Earth Sciences

More VideoLinks >>>